Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

Emilia Antonio presenting at pandemic pact meeting

Researchers from the PSI Policy and Practice Group have published the first mapping of research priority-setting exercises for high-consequence pathogens. 

Disease outbreaks caused by high-consequence pathogens such as H5N1 virus, Ebola virus, Zika virus and SARS-CoV-2 have the potential to lead to devastating morbidity and mortality globally.  

When outbreaks occur, research prioritisation is essential to support the allocation of limited resources while maximising impact.  This is especially true in the context of high-consequence pathogens, when research can only be undertaken whilst the outbreak is occurring and research opportunities are dependent on the unpredictability of outbreaks.   

The present study identifies opportunities for improvement and greater alignment to existing standards for enhancing the effectiveness of future research prioritisation exercises.  

 

Read the full story on the Pandemic Sciences Institute website.